Sirio Pharma Co., Ltd. (SHE:300791)

Sirio Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,630	6,167	6,293	6,637	7,513	11,035
Market Cap Growth	11.68%	-2.01%	-5.18%	-11.66%	-31.92%	123.46%
Enterprise Value	7,827	7,186	7,062	6,079	7,014	10,638
Last Close Price	21.67	19.82	19.44	20.39	22.75	33.20
PE Ratio	19.14	18.97	22.39	31.26	32.41	42.88
Forward PE	24.14	15.13	19.62	25.53	-	-
PS Ratio	1.49	1.46	1.76	2.65	3.17	5.34
PB Ratio	2.41	2.34	2.45	2.46	2.95	5.06
P/TBV Ratio	3.90	3.95	4.42	2.81	3.38	5.88
P/FCF Ratio	32.14	39.83	-	43.90	-	114.44
P/OCF Ratio	9.53	10.88	16.30	14.92	22.01	34.53
EV/Sales Ratio	1.76	1.71	1.97	2.42	2.96	5.15
EV/EBITDA Ratio	12.53	11.74	11.83	16.57	18.49	30.09
EV/EBIT Ratio	17.98	16.74	18.77	25.06	24.95	38.85
EV/FCF Ratio	37.95	46.41	-	40.21	-	110.32
Debt / Equity Ratio	0.62	0.61	0.53	0.35	0.34	0.02
Debt / EBITDA Ratio	2.73	2.48	2.16	2.50	2.27	0.10
Debt / FCF Ratio	8.27	10.38	-	6.20	-	0.36
Asset Turnover	0.80	0.79	0.76	0.63	0.73	0.83
Inventory Turnover	5.56	6.01	7.00	7.36	6.34	5.97
Quick Ratio	1.35	1.82	1.88	4.62	4.88	2.59
Current Ratio	1.89	2.45	2.57	5.18	5.76	3.42
Return on Equity (ROE)	10.94%	10.83%	9.12%	8.09%	9.81%	12.47%
Return on Assets (ROA)	4.87%	5.02%	5.01%	3.79%	5.43%	6.83%
Return on Invested Capital (ROIC)	10.04%	11.49%	12.90%	9.94%	12.54%	14.22%
Return on Capital Employed (ROCE)	9.10%	9.20%	8.50%	6.50%	8.10%	12.10%
Earnings Yield	5.21%	5.27%	4.47%	3.20%	3.09%	2.33%
FCF Yield	3.11%	2.51%	-1.04%	2.28%	-2.44%	0.87%
Dividend Yield	2.31%	2.52%	3.35%	1.01%	1.04%	0.71%
Payout Ratio	49.89%	67.56%	29.83%	35.84%	31.29%	10.05%
Buyback Yield / Dilution	-0.24%	0.36%	0.82%	4.47%	-5.00%	-23.77%
Total Shareholder Return	2.04%	2.88%	4.17%	5.49%	-3.96%	-23.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.